BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 27846801)

  • 1. Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor.
    Stepanova M; Sayiner M; de Avila L; Younoszai Z; Racila A; Younossi ZM
    BMC Gastroenterol; 2016 Nov; 16(1):137. PubMed ID: 27846801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
    Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
    Hepatology; 2019 Jun; 69(6):2381-2395. PubMed ID: 30706517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation from anti-hepatitis C virus-positive donors: our experience.
    Álvaro E; Abradelo M; Fuertes A; Manrique A; Colina F; Alegre C; Calvo J; García M; García-Sesma A; Cambra F; Sanabria R; Moreno E; Jimenez C
    Transplant Proc; 2012; 44(6):1475-8. PubMed ID: 22841188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis C.
    Shaikh OS; Rogal S; Malik A; Sharma V; Cacciarelli T
    Exp Clin Transplant; 2020 Oct; 18(5):605-611. PubMed ID: 31324136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
    Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplant for hepatitis C virus: effect of using older donor grafts on short- and medium-term survival.
    Doyle MB; Anderson CD; Vachharajani N; Lowell JA; Shenoy S; Lisker-Melman M; Korenblat K; Crippin JS; Chapman WC
    Arch Surg; 2008 Jul; 143(7):679-85; discussion 685. PubMed ID: 18645111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients: A Potential Cost-Effective Approach to Save Lives?
    Trotter PB; Summers DM; Ushiro-Lumb I; Robb M; Bradley JA; Powell J; Watson CJE; Neuberger J
    Transplantation; 2018 Apr; 102(4):664-672. PubMed ID: 29166338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
    N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation in the United States.
    Qiu J; Ozawa M; Terasaki PI
    Clin Transpl; 2005; ():17-28. PubMed ID: 17424722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implications for policies on organ procurement.
    Bouthot BA; Murthy BV; Schmid CH; Levey AS; Pereira BJ
    Transplantation; 1997 Mar; 63(6):849-53. PubMed ID: 9089225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients.
    Gasink LB; Blumberg EA; Localio AR; Desai SS; Israni AK; Lautenbach E
    JAMA; 2006 Oct; 296(15):1843-50. PubMed ID: 17047214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation from old donors into HCV and non-HCV recipients.
    Baccarani U; Adani GL; Toniutto P; Sainz M; Lorenzin D; Viale PL; Ramacciato G; Risaliti A; Bresadola F
    Transplant Proc; 2004 Apr; 36(3):527-8. PubMed ID: 15110581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transplant survival is improved for hepatitis C recipients who are RNA negative at time of liver transplantation.
    Fortune BE; Martinez-Camacho A; Kreidler S; Gralla J; Everson GT
    Transpl Int; 2015 Aug; 28(8):980-9. PubMed ID: 25818896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Utilization and Discard of Hepatitis C-Infected Donor Livers in the Recent Era.
    Bowring MG; Kucirka LM; Massie AB; Luo X; Cameron A; Sulkowski M; Rakestraw K; Gurakar A; Kuo I; Segev DL; Durand CM
    Am J Transplant; 2017 Feb; 17(2):519-527. PubMed ID: 27456927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: Analysis of United States national data.
    Gupta G; Kang L; Yu JW; Limkemann AJ; Garcia V; Bandyopadhyay D; Kumar D; Fattah H; Levy M; Cotterell AH; Sharma A; Bhati C; Reichman T; King AL; Sterling R
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28712111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients.
    Luckett K; Kaiser TE; Bari K; Safdar K; Schoech MR; Apewokin S; Diwan TS; Cuffy MC; Anwar N; Shah SA
    J Am Coll Surg; 2019 Apr; 228(4):560-567. PubMed ID: 30586641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UNOS Liver Registry: ten year survivals.
    Waki K
    Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine.
    Jain A; Orloff M; Abt P; Kashyap R; Mohanka R; Lansing K; Kelley M; Bozorgzadeh A
    Transplant Proc; 2005 Sep; 37(7):3187-9. PubMed ID: 16213345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
    Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
    Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant outcomes of patients with and without hepatitis C virus infection according to donor age and gender matching.
    Grąt M; Kornasiewicz O; Lewandowski Z; Ligocka J; Grąt K; Wronka KM; Zieniewicz K; Krawczyk M
    Ann Transplant; 2013 Dec; 18():705-15. PubMed ID: 24361968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.